/* mobile /* end mobile MEDDESKTOP: July 2010

Wednesday, July 21, 2010

Recallr: Vialipro Dietary Supplement: Recalled.

Good Health, Inc. is conducting a voluntary recall after an FDA lab analyses found that the product tested from certain batches of Vialipro contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED) making this product an unapproved drug. The undeclared ingredient may pose a threat to the consumer because the interaction of the analogue with some prescription drugs (such as nitroglycerin) may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take other prescription drugs.
BACKGROUND: This product is currently being sold as a dietary supplement throughout the U.S. The affected lot numbers being recalled can be found in the company's Press Release.
Recallr: Vialipro Dietary Supplement: Recalled.

Sunday, July 04, 2010

Bilski vs. Kappos : How The Decision Affect Biotech Patents

Bilski claims being thrown out and the same decision paving the path for Medical Methods being patentable : Biotech companies will now look to patent medical methods and the whole industry will be in an upheaval. Biotech startup companies are finding their stocks going up and I wonder if whole medical professioon would choke up with all these patents in the years to come.
You can read more about the  Bilski vs. Kappos effect on industry at PatentDocs and about Medical Methods being patentable at patentlyo.
It is hard to understand these patents and cases and reading these article might shed some light, if you feel the same way about these matters as I am.


Related Posts Widget for Blogs by LinkWithin